LASIK Should Carry Warnings of Possible Complications, FDA Says
New guidance says complications can include dry eyes, double vision, difficulty with night driving, chronic eye pain
New guidance says complications can include dry eyes, double vision, difficulty with night driving, chronic eye pain
The table provided is a review of notable updates that occurred in October 2022 for investigational products in development.
CyclASol is an investigational topical treatment of cyclosporine that contains no oils or surfactants and is preservative-free.
NOV03 is an investigational, water- and preservative-free nonsteroidal eye drop.
Cyclosporine ophthalmic emulsion is indicated to increase tear production in patients whose tear production is presumed to be suppressed due to ocular inflammation associated with keratoconjunctivitis sicca.
Review the October 2021 notable drug approvals.
Tyrvaya contains varenicline, a highly selective nicotinic acetylcholine agonist.
This week: The FDA authorize boosters for Moderna and Janssen and okay ‘mixing and matching’ of vaccines for the booster dose. The first interchangeable biosimilar to Humira is approved. Also there’s approvals in dry eye disease, pain management and opioid overdoses.
Tyrvaya contains varenicline, a highly selective nicotinic acetylcholine agonist.
The over-the-counter product may be used as a protectant against further eye irritation and to relieve dryness of the eye.